InvestHK leads delegation to Europe showcasing Hong Kong's strengths as leading family office hub (with photos)
******************************************************************************************
During the visit, Mr Fong and the delegation held a series of in-depth exchanges with European family offices, family representatives, asset owners, wealth managers and professional service providers. These engagements included roundtables, panel sessions, high-level forums, investor luncheons and one-on-one meetings. The meetings highlighted Hong Kong's advantages as Asia's leading international financial centre - an open-architecture capital market. The robust legal system in Hong Kong and the unique positioning under "one country, two systems" showcase the city as the ideal hub for European investors seeking to access Chinese Mainland and Asian markets.
Mr Fong said, "As a true international financial centre and Asia's largest cross-border wealth management hub, Hong Kong offers unparalleled advantages for global families seeking long-term and diversified growth. With the Government's dedicated FamilyOfficeHK team and a comprehensive suite of facilitation measures, we welcome European families to establish a presence in Hong Kong, expand their businesses, and capture the immense growth opportunities in the Guangdong-Hong Kong-Macao Greater Bay Area and the Mainland."
The Founder and Chief Executive Officer of Strela Capital GmbH, Ms Ekaterina Tattersall, pointed out, "Switzerland has long been recognised as a trusted hub for cross-border asset management in Europe, and Hong Kong plays an equally vital role in the Asian region. Both markets boast robust regulatory frameworks, deep financial expertise, and global connectivity as their core advantages. For us, Hong Kong is an indispensable extension of our global wealth strategy."
The Director of Bernina Bioinvest, a private investment company focused on early-stage biotech and medtech, Dr Bettina Ernst, said, "Hong Kong's growing life sciences ecosystem - combining academic research, clinical networks, and capital - makes it a compelling base for early-stage biotech and medtech innovation. For investors like us, the city's regional connectivity and regulatory openness create practical pathways from laboratory ideas to clinical and commercial milestones. Hong Kong sits at a valuable intersection of talent, research, and partnerships across Asia, which is an excellent location for investing in innovation. For early-stage biotech and medtech companies, access to universities, clinicians, and cross-border collaborators helps accelerate validation and scale, which is essential for translating science into patient impact."
The Managing Director and Chief Executive Officer of Wings Securities Limited, Mr Cliff Ip, one of the members of the Hong Kong delegation to Europe, said, "This trip was an exciting step in strengthening the connection between Hong Kong and European family offices. It opened doors for vibrant exchanges of investment ideas and sparked strong enthusiasm on both sides to explore co-investment opportunities. Embracing diversification across Hong Kong, Chinese Mainland, Asia and Europe is proving to be one of the powerful strategies for enhancing portfolio resilience. With world-class infrastructure, a strong talent pool, and resolute government support for the development of the family office sector, Hong Kong has firmly established itself as an essential player in the global family office dialogue."
"The Chief Executive's 2025 Policy Address" emphasises continued growth and support for the family office sector, including further enhancing preferential tax regimes for funds, single family offices and the New Capital Investment Entrant Scheme.
Ends/Friday, September 26, 2025
Issued at HKT 18:15
Issued at HKT 18:15
NNNN
Photo
